Rep. Griffith’s Compounding Draft Ties FDA Inspections To State Reporting
This article was originally published in The Pink Sheet Daily
Executive Summary
Rep. Griffith circulates a discussion draft with new procedures for states to tell FDA when they have found problems at a compounder, but only then could the agency inspect the facility.